Intravenous fluids in sepsis: What to use and what to avoid

Current Opinion in Critical Care

Volumn 19, Issue 6, 2013, Pages 537-543

  Karakala, Nithin ^a   Raghunathan, Karthik ^b   Shaw, Andrew D ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

albumin; balanced crystalloids; fluid resuscitation; hydroxyethyl starch; sepsis

Indexed keywords

ACETIC ACID; ACETIC ACID PLUS GLUCONATE SODIUM PLUS MAGNESIUM CHLORIDE PLUS POTASSIUM CHLORIDE PLUS SODIUM CHLORIDE; ALBUMIN; AMYLASE; AMYLOPECTIN; CREATININE; FUROSEMIDE; GLUCONIC ACID; HETASTARCH; INFUSION FLUID; INSULIN; LACTIC ACID; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; OCTANOIC ACID; SODIUM CHLORIDE;

ACUTE KIDNEY FAILURE; ACUTE LUNG INJURY; ADULT RESPIRATORY DISTRESS SYNDROME; BACTERIAL PERITONITIS; BICARBONATE BLOOD LEVEL; BIOACCUMULATION; BLOOD PH; BODY WEIGHT; COLLOID; COMORBIDITY; CREATININE BLOOD LEVEL; CRITICALLY ILL PATIENT; CRYSTALLOID; DIURESIS; ENTERIC FEEDING; FLUID BALANCE; FLUID RESUSCITATION; GLOMERULUS FILTRATION RATE; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART PERFORMANCE; HEMODILUTION; HUMAN; HYPERCHLOREMIC ACIDOSIS; HYPOALBUMINEMIA; INSULIN TREATMENT; KIDNEY BLOOD FLOW; LACTIC ACIDOSIS; METABOLIC ACIDOSIS; MOLECULAR WEIGHT; MORTALITY; NEPHROSIS; NONHUMAN; ONCOTIC PRESSURE; OSMOLALITY; PLASMA CLEARANCE; PLASMA RENIN ACTIVITY; RENAL REPLACEMENT THERAPY; RESUSCITATION; REVIEW; SEPSIS; SEPTIC SHOCK; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; TISSUE PERFUSION; URINE VOLUME;

ALBUMINS; COLLOIDS; CRITICAL CARE; FEMALE; FLUID THERAPY; HUMANS; HYDROXYETHYL STARCH DERIVATIVES; INFUSIONS, INTRAVENOUS; ISOTONIC SOLUTIONS; MALE; PATIENT SELECTION; RESUSCITATION; RISK ASSESSMENT; SEPSIS;

EID: 84888151669     PISSN: 10705295     EISSN: 15317072     Source Type: Journal    
DOI: 10.1097/MCC.0000000000000028     Document Type: Review

References (58)

1. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-1310 (Pubitemid 32641789)
2. Wheeler DS, Wong HR, Zingarelli B. Pediatric sepsis. Part I. Children are not small adults!. Open Inflamm J 2011; 4:4-15
3. Levy MM, Dellinger RP, Townsend SR, et al. The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis. Crit Care Med 2010; 38:367-374
4. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377
5. Early Goal-Directed Therapy Collaborative Group of Zhejiang Province. The effect of early goal-directed therapy on treatment of critical patients with severe sepsis/septic shock: a multicenter, prospective, randomized, controlled study. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue 2010; 22:331-334
6. Shaw AD, Kellum JA. The risk of AKI in patients treated with intravenous solutions containing hydroxyethyl starch. Clin J Am Soc Nephrol 2013; 8:497-503
7. Boyd JH, Forbes J, Nakada TA, et al. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 2011; 39:259-265
8. Murphy CV, Schramm GE, Doherty JA, et al. The importance of fluid management in acute lung injury secondary to septic shock. Chest 2009; 136:102-109
9. Alsous F, Khamiees M, DeGirolamo A, et al. Negative fluid balance predicts survival in patients with septic shock: a retrospective pilot study. Chest 2000; 117:1749-1754 (Pubitemid 30413373)
10. Maitland K, Kiguli S, Opoka RO, et al. Mortality after fluid bolus in African children with severe infection. N Engl J Med 2011; 364:2483-2495
11. SAFE Study Investigators, Australian and New Zealand Intensive Care Society Clinical Trials Group, Australian Red Cross Blood Service, George Institute for International Health. Myburgh J, Cooper DJ, Finfer S, et al. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 2007; 357:874-884 (Pubitemid 47347321)
12. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised controlled trials. BMJ 1998; 317:235-240
13. Roberts I, Edwards P, McLelland B. More on albumin. Use of human albumin in UK fell substantially when systematic review was published. BMJ 1999; 318:1214-1215
14. Wilkes MM, Navickis RJ. Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001; 135:149-164 (Pubitemid 32738309)
15. Dubois MJ, Orellana-Jimenez C, Melot C, et al. Albumin administration improves organ function in critically ill hypoalbuminemic patients: a prospective, randomized, controlled, pilot study. Crit Care Med 2006; 34:2536-2540 (Pubitemid 44413049)
16. Finfer S, Bellomo R, Boyce N, et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350:2247-2256 (Pubitemid 38669207)
17. Goldwasser P, Feldman J. Association of serum albumin and mortality risk. J Clin Epidemiol 1997; 50:693-703 (Pubitemid 27341819)
18. Wiedermann CJ, Dunzendorfer S, Gaioni LU, et al. Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trials. Crit Care 2010; 14:R191
19. Vincent JL, Dubois MJ, Navickis RJ, Wilkes MM. Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials. Ann Surg 2003; 237:319-334 (Pubitemid 38176446)
20. Chou CD, Yien HW, Wu DM, Kuo CD. Albumin administration in patients with severe sepsis due to secondary peritonitis. J Chin Med Assoc 2009; 72:243-250
21. Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999; 341:403-409 (Pubitemid 29362513)
22. Mehta RL, Pascual MT, Soroko S, Chertow GM, PICARD Study Group. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA 2002; 288:2547-2553 (Pubitemid 35386889)
23. Martin GS, Mangialardi RJ, Wheeler AP, et al. Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury. Crit Care Med 2002; 30:2175-2182 (Pubitemid 35191564)
24. Abstracts of the 32nd International Symposium on Intensive Care and Emergency Medicine; 20-23 March 2012; Brussels, Belgium. Crit Care 2012; 16(Suppl. 1):P1-520
25. Zoellner H, Hofler M, Beckmann R, et al. Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. J Cell Sci 1996; 109 (Pt 10):2571-2580 (Pubitemid 26377532)
26. Bolitho C, Bayl P, Hou JY, et al. The antiapoptotic activity of albumin for endothelium is mediated by a partially cryptic protein domain and reduced by inhibitors of G-coupled protein and PI-3 kinase, but is independent of radical scavenging or bound lipid. J Vasc Res 2007; 44:313-324 (Pubitemid 46956834)
27. Quinlan GJ, Mumby S, Martin GS, et al. Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Crit Care Med 2004; 32:755-759 (Pubitemid 38340073)
28. Mizzi A, Tran T, Karlnoski R, et al. Voluven, a new colloid solution. Anesthesiol Clin 2011; 29:547-555
29. Bellmann R, Feistritzer C, Wiedermann CJ. Effect of molecular weight and substitution on tissue uptake of hydroxyethyl starch: a meta-analysis of clinical studies. Clin Pharmacokinet 2012; 51:225-236
30. Schortgen F, Lacherade JC, Bruneel F, et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001; 357:911-916 (Pubitemid 32247279)
31. Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358:125-139
32. Weidler B, von Bormann B, Sommermeyer K, et al. Pharmacokinetic parameters as criteria for clinical use of hydroxyethyl starch preparations. Arzneimittelforschung 1991; 41:494-498
33. Asskali F, Forster H. The accumulation of different substituted hydroxyethyl starches (HES) following repeated infusions in healthy volunteers. Anasthesiol Intensivmed Notfallmed Schmerzther 1999; 34:537-541 (Pubitemid 29466077)
34. Lehmann GB, Asskali F, Boll M, et al. HES 130/0.42 shows less alteration of pharmacokinetics than HES 200/0.5 when dosed repeatedly. Br J Anaesth 2007; 98:635-644 (Pubitemid 47078670)
35. Waitzinger J, Bepperling F, Pabst G, et al. Pharmacokinetics and tolerability of a new hydroxyethyl starch (HES) specification [HES (130/0.4)] after singledose infusion of 6% or 10% solutions in healthy volunteers. Clin Drug Investig 1998; 16:151-160 (Pubitemid 28430059)
36. Jungheinrich C, Scharpf R, Wargenau M, et al. The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 ml) in mild-to-severe renal impairment. Anesth Analg 2002; 95:544-551. [table of contents].. (Pubitemid 35006837)
37. Myburgh JA, Finfer S, Bellomo R, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012; 367:1901-1911
38. Macedo E, Bouchard J, Soroko SH, et al. Fluid accumulation, recognition and staging of acute kidney injury in critically-ill patients. Crit Care 2010; 14:R82
39. Guidet B, Martinet O, Boulain T, et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study. Crit Care 2012; 16:R94
40. Perner A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus Ringers acetate in severe sepsis. N Engl J Med 2012; 367:124-134
41. Silva PL, Guldner A, Uhlig C, et al. Effects of intravascular volume replacement on lung and kidney function and damage in nonseptic experimental lung injury. Anesthesiology 2013; 118:395-408
42. Awad S, Allison SP, Lobo DN. The history of 0.9% saline. Clin Nutr 2008; 27:179-188
43. Shaw AD, Bagshaw SM, Goldstein SL, et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg 2012; 255:821-829
44. Hamburger HJ. A discourse on permeability in physiology and pathology. Lancet 1921; 198:1039-1045
45. Lorenz JN, Weihprecht H, Schnermann J, et al. Renin release from isolated juxtaglomerular apparatus depends on macula densa chloride transport. Am J Physiol 1991; 260 (4 Pt 2):F486-F493
46. Kotchen TA, Luke RG, Ott CE, et al. Effect of chloride on renin and blood pressure responses to sodium chloride. Ann Intern Med 1983; 98 (5 Pt 2): 817-822 (Pubitemid 13135269)
47. Wilcox CS. Regulation of renal blood flow by plasma chloride. J Clin Invest 1983; 71:726-735 (Pubitemid 13160821)
48. Chowdhury AH, Cox EF, Francis ST, Lobo DN. A randomized, controlled, double-blind crossover study on the effects of 2-L infusions of 0.9% saline and plasma-lyte(R) 148 on renal blood flow velocity and renal cortical tissue perfusion in healthy volunteers. Ann Surg 2012; 256:18-24
49. Yunos NM, Bellomo R, Hegarty C, et al. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 2012; 308:1566-1572
50. Reid F, Lobo DN, Williams RN, et al. (Ab)normal saline and physiological Hartmanns solution: a randomized double-blind crossover study. Clin Sci (Lond) 2003; 104:17-24 (Pubitemid 36249919)
51. Khajavi MR, Etezadi F, Moharari RS, et al. Effects of normal saline vs. lactated Ringers during renal transplantation. Ren Fail 2008; 30:535-539 (Pubitemid 351874066)
52. Wilkes NJ, Woolf R, Mutch M, et al. The effects of balanced versus salinebased hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesth Analg 2001; 93:811-816 (Pubitemid 32905960)
53. Stewart PA. Modern quantitative acid-base chemistry. Can J Physiol Pharmacol 1983; 61:1444-1461 (Pubitemid 14190843)
54. Gunnerson KJ, Saul M, He S, Kellum JA. Lactate versus nonlactate metabolic acidosis: a retrospective outcome evaluation of critically ill patients. Crit Care 2006; 10:R22
55. Kellum JA, Song M, Li J. Lactic and hydrochloric acids induce different patterns of inflammatory response in LPS-stimulated RAW 264.7 cells. Am J Physiol Regul Integr Comp Physiol 2004; 286:R686-R692 (Pubitemid 38374999)
56. Balogh Z, McKinley BA, Holcomb JB, et al. Both primary and secondary abdominal compartment syndrome can be predicted early and are harbingers of multiple organ failure. J Trauma 2003; 54:848-859; discussion 859- 861..
57. Raghunathan K, Shaw AD, Bagshaw SM. Fluids are drugs: type, dose and toxicity. Curr Opin Crit Care 2013; 19:290-298
58. Dellinger RP, Levy MM, Rhodes A, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock. Intensive Care Med 2013; 39:165-228.